Ketamine, esketamine, and ECT can rapidly ease suicidal thoughts, but evidence for preventing attempts or deaths remains limited—see what’s proven.
Poll|Articles|January 15, 2024
Has a Patient of Yours Died by Suicide in the Past 5 Years?
Author(s)Psychiatric Times Editors
Listen
0:00 / 0:00
Key Takeaways
- The cover story will address suicide, supported by a series of polls to gather insights from healthcare professionals.
- Professionals are invited to share experiences of increased suicidal ideation or patient suicides to inform the story.
Take our poll!
Advertisement
In preparation for our March cover story, we will be releasing a series of polls on suicide.
Has a patient of yours committed suicide in the past 5 years?
The last question can be found
If you have seen increased suicidal ideation in your patients, or if you've had a patient commit suicide, share more of your experience with us at
Advertisement
Related to this article
Learn how clozapine, lithium, ketamine, and antidepressants fit into suicide prevention, from rapid crisis relief to long-term risk reduction.
Can hormones flag suicide risk in schizophrenia? Review links cortisol, thyroid and testosterone shifts—and clozapine/lithium pathways—to risk.
How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.
In this case exploration, a teen survives a gun injury yet denies self-harm, pushing clinicians to read beyond words and plan safety when suicide intent is unclear.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psychiatric Pipeline in Review: Quarter 3, 2026
2
VA Expands Informed Consent Requirements for Psychotropic Medications Starting in 2027
3
Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression
4
September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
5